Amarin Corp Plc (AMRN)

[bogatie]

JL - thanks for the compliment (especially coming from someone with your scientific background). I passed it to investor relations and perhaps not surprisingly, they were aware of the post and it contents. Despite what some might say -we "retail" investors can influence things. Amarin clearly pays attention to the ideas passed around here. Hopefully, they have already been sorting the data on water and fat soluble statins. Also hope they have been getting as much data as possible on mineral oil that was discovered after WWII. Every little dotted i and crossed t could help with the FDA. After the 2013 ADCOM, I would not doubt in the least that there will be someone on a panel (like Hiatt) trying to cast doubt on every last aspect of REDUCE-IT. If you recall W. Hiatt even started discussing how he didn't think the REDUCE-IT primary end-point wasn't correct. He started laying the work for sabotaging REDUCE-IT back in 2013. I guess the good doctor was unaware that angina is usually included in all these CV trials. I remain very cautious - how the FDA let someone who had received payments from AstraZeneca, who had bought Omthera two months prior, sit on that panel shows the lack of due diligence one can come to expect from bureaucrats.